Form 4 holding
CEO, Director
KalVista Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 211,203
- Estimated value
- $2,981,088
- Report date
- 20 Feb 2024
- Price
- $14.11
- Ownership
- Direct
Thomas Andrew Crockett - CEO, Director at KalVista Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- CEO, Director
- Issuer ticker
- KALV
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Thomas Andrew Crockett since 08 Sep 2025
Reported holdings for Thomas Andrew Crockett in KalVista Pharmaceuticals, Inc.
Form 4 holding
CEO, Director
KalVista Pharmaceuticals, Inc.
- Security class
- Performance Stock Units
- Shares / value
- 62,500
- Estimated value
- $938,081
- Report date
- 17 Feb 2024
- Price
- $15.01
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CEO, Director
KalVista Pharmaceuticals, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 48,612
- Estimated value
- $729,632
- Report date
- 17 Feb 2024
- Price
- $15.01
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CEO, Director
KalVista Pharmaceuticals, Inc.
- Security class
- Performance Stock Unit
- Shares / value
- 0
- Estimated value
- Report date
- 17 Nov 2023
- Price
- $8.23
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Thomas Andrew Crockett in KalVista Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.